Back to Creative Planning Creative Planning

ACADACAD
28 quarters

Position history for Creative PlanningCreative Planning's holdings in ACADIA Pharmaceuticals Inc.

Creative Planning holds 43,862 shares of ACAD (ACADIA Pharmaceuticals Inc.), worth $1.1M as of 2026-Q2. The position was decreased (-7.6% shares). ACAD represents 0.0% of Creative Planning's portfolio.

Current Value

$1.1M

Current Shares

43,862

Total Value Change

+$532,709

Total Shares Change

+8,204

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
43,862
-7.6%
$1.1M0.0%$25.30
0
2026-Q1
Increased
47,485
+7.8%
$1.1M0.0%$22.50
27
2025-Q4
Increased
44,031
+21.1%
$1.2M0.0%$26.70
30
2025-Q3
Increased
36,349
+25.0%
$775,6880.0%$21.32
30
2025-Q2
Decreased
29,075
-28.5%
$627,1480.0%$22.12
0
2025-Q1
Decreased
40,644
-9.6%
$675,0970.0%$17.07
0
2024-Q4
Increased
44,954
+79.4%
$824,9060.0%$16.69
38
2024-Q3
Increased
25,061
+71.4%
$385,4380.0%$15.69
35
2024-Q2
New
14,620
-
$237,5750.0%$16.25
32
2024-Q1
Exited
0
-100.0%
$00.0%$18.49
0
2023-Q4
New
7,243
-
$226,7780.0%$31.31
32
2022-Q4
Exited
0
-100.0%
$00.0%$15.92
0
2022-Q3
Decreased
13,202
-5.8%
$216,0000.0%$16.14
0
2022-Q2
Decreased
14,012
-32.7%
$197,0000.0%$14.22
0
2022-Q1
Increased
20,815
+45.7%
$504,0000.0%$24.41
33
2021-Q4
Increased
14,290
+2.4%
$334,0000.0%$23.54
24
2021-Q3
Decreased
13,956
-6.3%
$232,0000.0%$16.96
0
2021-Q2
Decreased
14,891
-4.7%
$363,0000.0%$24.13
0
2021-Q1
Decreased
15,631
-47.5%
$403,0000.0%$25.71
0
2020-Q4
Increased
29,753
+11.7%
$1.6M0.0%$53.69
29
2020-Q3
Increased
26,648
+129.3%
$1.1M0.0%$40.41
41
2020-Q2
Decreased
11,622
-15.3%
$563,0000.0%$48.16
0
2020-Q1
Decreased
13,722
-54.5%
$580,0000.0%$41.32
0
2019-Q4
Decreased
30,122
-9.1%
$1.3M0.0%$43.16
0
2019-Q3
Decreased
33,141
-3.6%
$1.2M0.0%$36.78
0
2019-Q2
Increased
34,366
+0.1%
$919,0000.0%$26.73
25
2019-Q1
Decreased
34,338
-3.7%
$922,0000.0%$26.85
0
2018-Q4
New
35,658
-
$577,0000.0%$15.65
34

Other major holders of ACAD: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used